Health and Medicine

Health and Medicine

FSI’s researchers assess health and medicine through the lenses of economics, nutrition and politics. They’re studying and influencing public health policies of local and national governments and the roles that corporations and nongovernmental organizations play in providing health care around the world. Scholars look at how governance affects citizens’ health, how children’s health care access affects the aging process and how to improve children’s health in Guatemala and rural China. They want to know what it will take for people to cook more safely and breathe more easily in developing countries.

FSI professors investigate how lifestyles affect health. What good does gardening do for older Americans? What are the benefits of eating organic food or growing genetically modified rice in China? They study cost-effectiveness by examining programs like those aimed at preventing the spread of tuberculosis in Russian prisons. Policies that impact obesity and undernutrition are examined; as are the public health implications of limiting salt in processed foods and the role of smoking among men who work in Chinese factories. FSI health research looks at sweeping domestic policies like the Affordable Care Act and the role of foreign aid in affecting the price of HIV drugs in Africa.

Recent Scholarly Publications

Records 24 / 1113

The practitioner's dilemma: can we use a patient's race to predict genetics, ancestry, and the expected outcomes of treatment?

December 2005

Recent research has identified genetic traits that can be used in a laboratory setting to distinguish among global population groups.

Frequency of HIV Screening in the Veterans Health Administrations: Implications for Early Diagnosis of HIV Infection

December 2008

We evaluated the frequency of HIV testing across the Department of Veterans Affairs (VA), the largest provider of HIV care in the United States.

Evaluating Human Papillomavirus Vaccination Programs

November 2004

Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical cancer. Potential vaccines against high-risk HPV types are in clinical trials.

Alglucerase for Gaucher's Disease: Dose, Costs, and Benefits

December 1994

Can Technology Assessment Control Health Spending?

December 1994

Because medical technology is the most important controllable component of health spending growth, the success of strategies for limiting spending growth depends upon their impact on technology...

Cost-Effectiveness Analysis as a Measure of Value

December 1996

Cost-Effectiveness of Three Methods to Enhance the Sensitivity of Papanicolaou Testing

December 1999

Also a 1998 research report: Medical Advisory Panel, TEC Program, Blue Cross Blue Shield Association

Cost-Effectiveness of Screening for Carotid Stenosis in Asymptomatic Individuals

December 1997

Costs and Health Consequences of Cholesterol Screening for Asymptomatic Older Americans

December 1991

Creating the Costliest Orphan: The Orphan Drug Act in the Development of Ceredase

December 1992

Economic Foundations of Cost-Effectiveness Analysis

December 1997

Health Care Productivity

December 1997

Is High-Flux Dialysis Cost Effective?

December 1993

Low Molecular Weight Heparins Compared with Unfractionated Heparin for the Treatment of Acute Deep Vein Thrombosis: A Cost-Effectiveness Analysis

December 1999

Low-molecular-weight heparin preparations are as safe and effective as unfractionated heparin for the treatment of acute deep venous thrombosis.

Practice Guidelines and Cholesterol Policy

December 1991

One of the most striking pieces of medical news in the 1980s revealed the connection between high blood cholesterol and a person's likelihood of developing coronary artery disease.

Problems with the Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents

December 1995

Realistic Rigor in Cost-Effectiveness Methods

December 1999

Screening for Hypertension

December 1990

Task Force 6: Cost Effectiveness of Assessment and Management of Risk Factors

December 1996


rsd15 081 0344a Jay Bhattacharya Senior Fellow by Courtesy Professor, Medicine (CHP/PCOR)
1 RSD13 085 0052a 001 David Relman Senior Fellow Professor, Medicine, Professor, Microbiology and Immunology
Owens1 Douglas K. Owens Senior Fellow Professor, Medicine (CHP/PCOR)
Steve Luby Headshot Stephen P. Luby Senior Fellow Professor, Medicine (CHP/PCOR)
rsd15 081 0253a Paul H. Wise Senior Fellow Senior Fellow , Professor, Pediatrics (CHP/PCOR)
Joshua Salomon of Stanford Health Policy Joshua Salomon Senior Fellow Professor, Medicine CHP/PCOR
rsd15 055 0123a Grant Miller Senior Fellow Professor, Medicine (CHP/PCOR)
default people 100x120 Daniel P. Kessler Professor, Law, Professor, Political Economy
default people 100x120 Marcus W. Feldman Professor, Biology
Yock bio Paul Yock Professor, Medicine, Professor, Bioengineering
22940078479 cc5040fcbc o Eric Sun Assistant Professor, Anesthesiology
unknown Lin Zhu Research Engineer, CHP/PCOR